{{Rsnum
|rsid=4487645
|Gene=DNAH11
|Chromosome=7
|position=21898622
|Orientation=plus
|GMAF=0.2268
|Gene_s=DNAH11
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.8 | 47.8 | 43.4
| HCB | 2.9 | 38.7 | 58.4
| JPT | 3.5 | 30.1 | 66.4
| YRI | 0.7 | 11.6 | 87.8
| ASW | 0.0 | 22.8 | 77.2
| CHB | 2.9 | 38.7 | 58.4
| CHD | 2.8 | 22.0 | 75.2
| GIH | 4.0 | 24.8 | 71.3
| LWK | 1.8 | 20.0 | 78.2
| MEX | 12.1 | 39.7 | 48.3
| MKK | 0.6 | 21.8 | 77.6
| TSI | 16.7 | 46.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22120009
|Trait=None
|Title=Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.
|RiskAllele=C
|Pval=3E-14
|OR=1.3800
|ORtxt=None
}}

{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (hyperdiploidy)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=C
  |Pval=1E-9
  |OR=1.43
  |ORtxt=[1.27-1.60]
  }}

{{PMID Auto
|PMID=24449210
|Title=Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}